- Home
- CDNA vs ARQQ Comparison
CDNA vs ARQQ Comparison
Compare CDNA & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- ARQQ
- Stock Information
- Founded
- CDNA 1998
- ARQQ 2017
- Country
- CDNA United States
- ARQQ United Kingdom
- Employees
- CDNA N/A
- ARQQ N/A
- Industry
- CDNA Medical Specialities
- ARQQ Computer Software: Prepackaged Software
- Sector
- CDNA Health Care
- ARQQ Technology
- Exchange
- CDNA Nasdaq
- ARQQ Nasdaq
- Market Cap
- CDNA 712.2M
- ARQQ 622.8M
- IPO Year
- CDNA 2014
- ARQQ N/A
- Fundamental
- Price
- CDNA $18.03
- ARQQ $26.08
- Analyst Decision
- CDNA Buy
- ARQQ Strong Buy
- Analyst Count
- CDNA 7
- ARQQ 1
- Target Price
- CDNA $26.00
- ARQQ $60.00
- AVG Volume (30 Days)
- CDNA 1.2M
- ARQQ 556.1K
- Earning Date
- CDNA 11-04-2025
- ARQQ 11-21-2025
- Dividend Yield
- CDNA N/A
- ARQQ N/A
- EPS Growth
- CDNA N/A
- ARQQ N/A
- EPS
- CDNA 1.22
- ARQQ 0.48
- Revenue
- CDNA $357,998,000.00
- ARQQ $241,000.00
- Revenue This Year
- CDNA $12.73
- ARQQ $86.94
- Revenue Next Year
- CDNA $11.90
- ARQQ $1,017.32
- P/E Ratio
- CDNA $14.75
- ARQQ $60.29
- Revenue Growth
- CDNA 14.46
- ARQQ N/A
- 52 Week Low
- CDNA $10.96
- ARQQ $11.00
- 52 Week High
- CDNA $26.37
- ARQQ $62.00
- Technical
- Relative Strength Index (RSI)
- CDNA 67.03
- ARQQ 37.02
- Support Level
- CDNA $15.60
- ARQQ $21.59
- Resistance Level
- CDNA $17.09
- ARQQ $29.90
- Average True Range (ATR)
- CDNA 1.02
- ARQQ 3.23
- MACD
- CDNA 0.15
- ARQQ -0.57
- Stochastic Oscillator
- CDNA 95.64
- ARQQ 30.51
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.